Sort   by:  
 Page size 
UnknownPhase I Study of Safety, Tolerability, and Efficacy of Tebentafusp Using a Step-Up Dosing Regimen and Expansion in Patients With Metastatic Uveal Melanoma.
Not available
S-EPMC9177239 | biostudies-literature
UnknownImpact of reirradiation of painful osseous metastases on quality of life and function: a secondary analysis of the NCIC CTG SC.20 randomized trial.
Not available
S-EPMC4239305 | biostudies-literature
UnknownCediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial.
Not available
S-EPMC7903311 | biostudies-literature
UnknownChild Conduct Problems across Home and School Contexts: A Person-Centered Approach.
Not available
S-EPMC5926240 | biostudies-literature
UnknownPhase III randomized clinical trial comparing tremelimumab with standard-of-care chemotherapy in patients with advanced melanoma.
Not available
S-EPMC4878048 | biostudies-literature
UnknownTORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer.
Not available
S-EPMC9702982 | biostudies-literature
UnknownClinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial.
Not available
S-EPMC9671803 | biostudies-literature
UnknownStandard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial.
Not available
S-EPMC4648090 | biostudies-literature
UnknownAdjuvant Nivolumab versus Ipilimumab in Resected Stage III/IV Melanoma: 5-Year Efficacy and Biomarker Results from CheckMate 238.
Not available
S-EPMC10472092 | biostudies-literature
UnknownRucaparib or Physician's Choice in Metastatic Prostate Cancer.
Not available
S-EPMC10064172 | biostudies-literature
Sort   by:  
 Page size